Oslo, Norway, 1 December, RESPINOR AS, a Norwegian medical technology company advancing diaphragm monitoring in critical care, today announced that it has signed a distributor agreement with Arseus Medical, securing exclusive distribution of RESPINOR DXT in Belgium, the Netherlands, and Luxembourg. The agreement includes initial purchase commitments, marking the first commercial sales of RESPINOR DXT in the Benelux region.

RESPINOR DXT® is a non-invasive, ultrasound-based medical device designed to monitor diaphragm movement continuously and in real time. By providing objective, actionable data, the device supports clinicians during ventilator weaning and helps identify patients at increased risk of extubation failure, a key challenge in intensive care units worldwide.

“We are excited to partner with Arseus Medical, a well-established leader in distributing high-quality medical technologies across the Benelux region,”

said Trude Tingvoll, CEO, RESPINOR AS. “Their deep expertise and strong relationships with ICU clinicians make them an ideal partner as we take this important next step in our commercialization journey. This agreement validates the growing need for improved respiratory monitoring and brings RESPINOR DXT closer to the patients who need it most.”

Arseus Medical, part of the Arseus Group, is a leading provider of advanced medical equipment and solutions across the Benelux healthcare market. With a strong presence in critical care, anesthesia, and surgery, Arseus Medical is well positioned to introduce RESPINOR DXT to intensive care units throughout the region.

“We are proud to add RESPINOR DXT to our portfolio”

said Sarah Perneel, Business Unit Manager Arseus Hospital, Arseus Medical. “The ability to monitor diaphragm function non-invasively and continuously is a major advancement for ICU teams. We look forward to bringing this innovative technology to our customers and supporting improved patient outcomes during ventilator weaning.”

The agreement expands RESPINOR’s commercial presence in Europe and represents a pivotal milestone ahead of further international rollouts.

About RESPINOR‍

RESPINOR AS is a Norwegian medical technology company dedicated to transforming diaphragm monitoring in intensive care. Its first product, RESPINOR DXT, is CE-marked and clinically validated to support diaphragm monitoring in mechanically ventilated patients. RESPINOR partners with leading clinical institutions to bring innovative, evidence-based tools to the bedside.

About Arseus Medical‍

Arseus Medical is a leading distributor of high-quality medical devices and solutions across Belgium, the Netherlands, and Luxembourg. With a focus on critical care, surgery, and anesthesia, Arseus Medical provides advanced technologies and expert support to hospitals and healthcare professionals throughout the Benelux region.

Contact:
Trude Tingvoll
CEO, RESPINOR AS
t.tingvoll@respinor.com
+47 474 53 314

‍